Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000378364 | SCV000333331 | uncertain significance | not provided | 2015-08-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000803556 | SCV000943434 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2019-08-28 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with leucine at codon 102 of the CAPN3 protein (p.Pro102Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in combination with a second CAPN3 variant in an individual affected with limb-girdle muscular dystrophy (PMID: 29970176). ClinVar contains an entry for this variant (Variation ID: 282117). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |